OrbiMed-backed Bellus Health to list on NASDAQ

Laval, Québec-based clinical-stage biopharmaceutical company Bellus Health Inc has filed for a US$60 million public offering and to list on the NASDAQ under the ticker symbol "BLU." Jefferies, Cowen and Guggenheim are serving as lead underwriters. Bellus Health's backers include OrbiMed Advisors LLC, Power Corporation of Canada, Rocabe Investments Inc., New Leaf Venture Partners, First Manhattan Co and Samsara BioCapital.